Chemical structure of 7-Dehydroxylvancomycin B
Catalogue No.
CSL-185351
CAS No.
Not assigned
Molecular formula
C66H75Cl2N9O23
Molecular weight
1433.27
Parent drug
Vancomycin
Product type
Impurities, Pharmaceutical Reference Standards, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals, peptides, Chiral standards
Quick quote · CSL-185351Price and availability on request
ISO 17034:2016 · GLP

Tell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.

Need documents or a larger lot? Use the full quote form

Synonyms

  • De-Oxy-(2) Vancomycin B

More Vancomycin products

All 80 →
Chemical structure of (3S,6R,7R,22R,23S,26S,30aSa,36R,38aR)-3-(2-Amino-2-oxoethyl)-44-[[2-O-(3-amino-2,3,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-10,19-dichloro-7',22,28,30,32-pentahydroxy-6-[[(2R)-2-(methylamino)pentanoyl]amino]-2,5,24,38,39-pentaoxo-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-22H-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35-dimetheno-1H,13H-[1,6,9]0xadiazacyclohexadecino-[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic Acid
(3S,6R,7R,22R,23S,26S,30aSa,36R,38aR)-3-(2-Amino-2-oxoethyl)-44-[[2-O-(3-amino-2,3,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-10,19-dichloro-7',22,28,30,32-pentahydroxy-6-[[(2R)-2-(methylamino)pentanoyl]amino]-2,5,24,38,39-pentaoxo-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-22H-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35-dimetheno-1H,13H-[1,6,9]0xadiazacyclohexadecino-[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic AcidCSL-176012
Chemical structure of (3S,6R,7R,22R,23S,26S,30aSa,36R,38aR)-3-(2-Amino-2-oxoethyl)-44-[[2-O-(3-amino-2,3,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-19,45-dichloro-7,22,28,30,32-pentahydroxy-6—[[(2R)-2-(methylamino)pentanoyl]amino]-2,5,24,38,39-pentaoxo-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-22H-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35-dimethano-1H-13H-[1,6,9]oxadiazacyclohexadecino-[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic Acid
(3S,6R,7R,22R,23S,26S,30aSa,36R,38aR)-3-(2-Amino-2-oxoethyl)-44-[[2-O-(3-amino-2,3,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-19,45-dichloro-7,22,28,30,32-pentahydroxy-6—[[(2R)-2-(methylamino)pentanoyl]amino]-2,5,24,38,39-pentaoxo-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-22H-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35-dimethano-1H-13H-[1,6,9]oxadiazacyclohexadecino-[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic AcidCSL-176013
Chemical structure of (3S,6R,7R,22R,23S,26S,30aSa,36R,38aR)-3-(2-Amino-2-oxoethyl-44-[[2-O-(3-amino-2,3,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-10,19-dichloro-7,22,28,30,32-pentahydroxy-6-[[(2R)-4-methyl-2-(dimethylamino)pentanoyl]amino]-2,5,24,38,39-pentaoxo-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-22H-8,11:18,21-dietheno-23-36-(iminomethano)-13,16:31,35-dimetheno-1H,13H-[1,6,9]oxadiazacyclohexadecino-[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic Acid
(3S,6R,7R,22R,23S,26S,30aSa,36R,38aR)-3-(2-Amino-2-oxoethyl-44-[[2-O-(3-amino-2,3,6-trideoxy-3-O-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-10,19-dichloro-7,22,28,30,32-pentahydroxy-6-[[(2R)-4-methyl-2-(dimethylamino)pentanoyl]amino]-2,5,24,38,39-pentaoxo-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-22H-8,11:18,21-dietheno-23-36-(iminomethano)-13,16:31,35-dimetheno-1H,13H-[1,6,9]oxadiazacyclohexadecino-[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic AcidCSL-176015
Chemical structure of (RS2) Isomer of Demethylvancomycin B
(RS2) Isomer of Demethylvancomycin BCSL-187614